ANG Human

Angiogenin Human Recombinant
Shipped with Ice Packs
In Stock

Description

Chemical Properties of Angiotensin II

Angiotensin II is an octapeptide with the sequence DRVYIHPF (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe). Key chemical attributes include:

PropertyValue/DescriptionSource
Molecular FormulaC₅₀H₇₁N₁₃O₁₂
Molecular Weight1046.18 g/mol
CAS Number4474-91-3
Counter IonTrifluoroacetate salt
Purity≥96% (HPLC)

This peptide is synthesized as a free acid at the C-terminus and a free amine at the N-terminus . Lyophilized powder is the standard form for storage at -20°C .

Biological Roles and Mechanisms

Angiotensin II exerts systemic effects through interaction with two primary receptors:

  • AT₁ Receptor: Mediates vasoconstriction, sodium retention, and aldosterone release .

  • AT₂ Receptor: May counteract AT₁ effects via vasodilation and natriuresis .

Key Physiological Functions:

  1. Blood Pressure Regulation: Direct vasoconstriction and indirect effects via sympathetic activation .

  2. Fluid Balance: Stimulation of thirst and aldosterone-driven sodium reabsorption .

  3. Cardiac Hypertrophy: Chronic activation promotes left ventricular remodeling .

Therapeutic and Diagnostic Relevance

  • Hypertension Management: Targeted by ACE inhibitors and ARBs (e.g., losartan) to block AT₁ signaling .

  • Clinical Trials: Adverse events include thromboembolic events (12.9%) and tachycardia (8.6%) .

Emerging Research Directions

  • Genetic Diversity: The human pangenome initiative highlights population-specific variations in RAAS-related genes, impacting drug response .

  • AI-Driven Drug Discovery: Models like CODE-AE predict efficacy of novel compounds targeting Angiotensin II pathways .

PubChem and CAS REGISTRY

DatabaseKey AttributesSource
PubChemCID 172198; pharmacological classifications (C01CX09)
CAS REGISTRY4474-91-3; protein sequence integration

These resources provide standardized identifiers, bioactivity data, and cross-references to clinical trials .

Future Directions

  1. Personalized Medicine: Leveraging pangenomic data to tailor AT₂ receptor modulators .

  2. Toxicology: Assessing interactions with environmental disruptors (e.g., nanoplastics/PFAS) on protein stability .

  3. Metabolomics: Advanced AMS/HP-LC-MS for tracing ¹⁴C-labeled Angiotensin II in human AME studies .

Product Specs

Introduction
Angiogenin (ANG), a member of the RNase A family, plays a crucial role in the formation of new blood vessels (angiogenesis). It functions by cleaving tRNA within anticodon loops, generating tRNA-derived stress-induced fragments (tiRNAs). These tiRNAs have been shown to inhibit protein synthesis and promote the formation of stress granules. Additionally, ANG stimulates the synthesis of ribosomal RNA. Its interaction with RNH1 in vivo is essential for regulating its angiogenic activity.
Description
Recombinant Human ANG, expressed in E.coli, is a single, non-glycosylated polypeptide chain consisting of 144 amino acids (residues 25-147). It has a molecular weight of 16.4 kDa. This protein is engineered with a 21 amino acid His-Tag at the N-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
The ANG solution is supplied at a concentration of 0.5 mg/ml. It is formulated in a buffer containing 20mM Tris-HCl (pH 8.0), 10% glycerol, and 0.4M Urea.
Stability
For short-term storage (up to 2-4 weeks), the product can be stored at 4°C. For long-term storage, it is recommended to store the product frozen at -20°C. To ensure stability during long-term storage, the addition of a carrier protein (0.1% HSA or BSA) is advised. It is important to avoid repeated freezing and thawing of the product.
Purity
The purity of the ANG protein is greater than 85.0% as determined by SDS-PAGE analysis.
Synonyms
Angiogenin, ANG, Ribonuclease 5, RNase 5, RNASE5, ribonuclease, RNase A family, 5, ALS9, HEL168, MGC22466, MGC71966, RNASE4.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MQDNSRYTHF LTQHYDAKPQ GRDDRYCESI MRRRGLTSPC KDINTFIHGN KRSIKAICEN KNGNPHRENL RISKSSFQVT TCKLHGGSPW PPCQYRATAG FRNVVVACEN GLPVHLDQSI FRRP.

Q&A

How do I formulate an effective research question?

Developing a strong research question is fundamental to successful scientific inquiry and requires systematic consideration of multiple components. Research shows that approximately one-third of project time may be invested in refining the primary study question, with retrospective analysis indicating that 30% of published articles would have benefited from major rewording of their research questions .

The PICOT framework provides a structured approach to formulating research questions by addressing five key components:

  • Population: Define your target population with appropriate eligibility criteria

  • Intervention: Specify the treatment, diagnostic test, or procedure being studied

  • Comparator: Establish appropriate control interventions

  • Outcome: Identify primary and secondary outcome measures

  • Time frame: Determine study duration and measurement intervals

Additionally, the FINER criteria help ensure your research question is not only well-structured but also practically viable:

ComponentCriteria
FeasibleEnsures adequacy of research design, guarantees funding, recruits target population strategically
InterestingEngages investigators, attracts readers, presents novel perspectives
NovelProvides different findings, generates new hypotheses, improves on existing methodologies
EthicalComplies with ethical standards, safeguards research principles, guarantees participant safety
RelevantGenerates new knowledge, contributes to clinical practice, stimulates further research

What are the essential steps in experimental design?

A systematic approach to experimental design involves five critical steps that establish the foundation for valid scientific inquiry:

  • Define your variables: Begin by clearly identifying independent variables (what you manipulate), dependent variables (what you measure), and controlling for extraneous variables that might influence your results .

  • Formulate a specific, testable hypothesis: Your hypothesis should articulate a predicted relationship between variables based on existing knowledge and theory .

  • Design experimental treatments: Carefully plan how you will manipulate your independent variable(s), considering appropriate levels or conditions that will provide meaningful contrast .

  • Assign subjects to groups: Determine whether a between-subjects design (different participants in each condition) or within-subjects design (same participants across all conditions) is most appropriate for your research question .

  • Plan measurement procedures: Establish reliable, valid methods for measuring your dependent variable, including appropriate instrumentation and data collection protocols .

How can I analyze and interpret contradictory findings in my research data?

Contradictions in research data present complex analytical challenges that require systematic approaches for resolution. Current research utilizing large language models (LLMs) for contradiction detection provides valuable methodological insights applicable to human analysis of self-contradictions in experimental data .

When confronting contradictory findings:

  • Categorize contradiction types: Identify whether contradictions represent direct logical oppositions, contextual inconsistencies, or temporal variations in data patterns .

  • Examine appearance scope: Assess whether contradictions appear within proximal data points or across distant sections of your dataset, as this affects interpretation strategies .

  • Evaluate contextual coherence: Consider whether seemingly contradictory findings might be contextually appropriate within different experimental conditions or theoretical frameworks .

  • Apply domain-specific knowledge: Utilize expertise in your field to distinguish between genuine contradictions and nuanced relationships that may appear contradictory to automated analysis or surface-level review .

Research demonstrates that even advanced analytical systems struggle with contradictions requiring nuanced context interpretation, suggesting the critical importance of combining computational tools with human expertise when evaluating complex scientific data .

What are effective approaches for analyzing volatile compounds in human breath for biomarker discovery?

The analysis of volatile compounds in human breath represents a promising frontier in biomarker discovery, though methodological challenges have limited clinical applications. Current research demonstrates that grouping volatile organic compounds into chemical functional groups based on metabolic and enzymatic pathways significantly enhances biomarker identification efficacy .

When implementing breath analysis for biomarker discovery:

  • Apply functional grouping approaches: Rather than focusing exclusively on individual compounds, classify volatile compounds into functional groups (e.g., methylated hydrocarbons, aldehydes) based on metabolic pathways .

  • Utilize advanced statistical methods: Implement principal component analysis, random forest algorithms, and linear discriminant analysis to identify patterns within grouped compounds .

  • Consider disease-specific metabolic alterations: Design your analysis to account for the distinct metabolic signatures associated with different pathological conditions .

Comparative statistical analysis demonstrates that the functional grouping approach doubles explanatory capacity from 19.1% to 38% relative to individual compound approaches. Furthermore, machine learning classification methods applied to functionally grouped compounds have achieved 93% classification accuracy for cancer biomarkers, highlighting the methodological advantage of this approach .

How can I optimize my use of Google's People Also Ask data for research question development?

Google's People Also Ask (PAA) feature provides valuable insights into search behavior patterns and can be leveraged to identify research questions that address knowledge gaps and user interests. PAAs appear in over 80% of English searches and reveal cascading question relationships when expanded .

To effectively utilize PAA data for research development:

  • Analyze question relationships: Examine how PAA questions relate to each other to understand conceptual hierarchies and knowledge gaps within your research domain .

  • Identify search behavior patterns: Use PAA data to understand how users refine their queries, revealing the progressive steps in information seeking that can inform research question development .

  • Assess query interpretation: Analyze how Google interprets queries through provided PAAs to understand conceptual associations within your research field .

  • Monitor temporal changes: Regularly check PAA results for your research topics to identify emerging questions and shifting interests that may signal new research opportunities .

Research indicates that complex queries typically require an average of eight searches for users to complete a task, suggesting that PAA data can reveal the multi-step cognitive process underlying information seeking in complex domains. This insight can be particularly valuable when formulating research questions that address complete knowledge needs rather than isolated inquiries .

What methodological considerations are important when designing studies to identify volatile biomarkers in human breath?

The identification of volatile biomarkers in human breath requires careful methodological consideration to address challenges of inconsistent and conflicting biomarker identification across studies. A comprehensive approach must address several key methodological considerations:

  • Chemical functional grouping: Organize volatile organic compounds into functional groups based on known metabolic and enzymatic pathways to enhance statistical power and biological relevance .

  • Multi-disease comparison: Design studies that examine volatile compounds across metabolically and physiologically distinct diseases to identify both shared and disease-specific biomarker patterns .

  • Statistical approach selection: Implement advanced statistical methods including principal component analysis for dimension reduction, random forest algorithms for classification, and linear discriminant analysis for group differentiation .

  • Validation protocols: Establish rigorous validation procedures to confirm biomarker reliability across diverse patient populations and sampling conditions .

Research demonstrates significant improvements in diagnostic accuracy when using functional grouping approaches, with studies achieving 93% classification accuracy for cancer using grouped volatile compounds compared to substantially lower accuracy with individual compound approaches .

How do I ensure ethical compliance when designing experimental research with human subjects?

Ethical considerations must be integrated throughout the research design process, particularly when working with human subjects. The FINER criteria specifically highlight ethical requirements as a fundamental component of quality research .

When designing ethical research:

  • Comply with local ethical committees: Ensure all protocols receive appropriate institutional review and approval before implementation .

  • Safeguard ethical research principles: Design studies that uphold core principles including:

    • Respect for autonomy through informed consent

    • Beneficence by maximizing potential benefits

    • Non-maleficence by minimizing potential harms

    • Justice through fair participant selection and equal treatment

  • Guarantee safety and reversibility: Design interventions that prioritize participant safety with clearly defined protocols for addressing adverse events .

  • Consider special populations: When working with vulnerable groups, implement additional protections appropriate to their specific needs and circumstances .

  • Plan for ethical data management: Establish protocols for data privacy, security, and appropriate sharing that protect participant confidentiality while supporting scientific transparency .

Research design decisions directly impact ethical compliance, including choices regarding control groups, intervention standardization, outcome measurement, and time frame considerations as outlined in the PICOT framework .

How can I effectively handle self-contradictions in research documentation and analysis?

Self-contradictions in research documentation present significant challenges for data interpretation and can undermine research validity if not properly addressed. Recent methodological advances in contradiction detection provide frameworks applicable to scientific documentation .

When addressing self-contradictions:

Research on contradiction detection demonstrates that even advanced analytical systems struggle with contradictions requiring nuanced context interpretation, highlighting the importance of careful human review in addition to automated approaches .

Product Science Overview

Introduction

Angiogenin is a 14-kilodalton ribonuclease enzyme that plays a crucial role in various physiological and pathological processes. It is involved in tumorigenesis, neuroprotection, inflammation, innate immunity, reproduction, tissue regeneration, and cellular stress responses . Human recombinant angiogenin is a synthetically produced version of this enzyme, designed to mimic its natural counterpart.

Discovery and Structure

Angiogenin was first discovered in 1985 by Bert L. Vallee and his colleagues. It is a member of the ribonuclease A superfamily and shares structural similarities with other ribonucleases. The enzyme consists of 123 amino acids and has a molecular weight of approximately 14 kDa . Its three-dimensional structure includes a characteristic ribonuclease fold, which is essential for its enzymatic activity.

Biological Functions

Angiogenin is known for its ability to induce angiogenesis, the process of forming new blood vessels from pre-existing ones. This function is critical for wound healing, tissue regeneration, and the growth of tumors. Angiogenin achieves this by binding to specific receptors on endothelial cells, stimulating their proliferation and migration .

In addition to its role in angiogenesis, angiogenin has several other biological functions:

  • Neuroprotection: Angiogenin has been shown to protect neurons from apoptosis (programmed cell death) and promote neuronal survival under stress conditions .
  • Inflammation and Immunity: Angiogenin modulates the immune response and has anti-inflammatory properties .
  • Stress Response: Under stress conditions, angiogenin accumulates in the cytoplasm and modulates the production of transfer RNA-derived stress-induced RNAs (tiRNAs), which contribute to translational inhibition and the formation of stress granules .
Recombinant Angiogenin

Human recombinant angiogenin is produced using recombinant DNA technology, typically in Escherichia coli (E. coli) expression systems. The recombinant protein is purified to high levels of purity, often exceeding 97% . It retains the biological activities of the natural enzyme, including its ribonucleolytic activity and ability to induce angiogenesis .

Clinical and Research Applications

Recombinant angiogenin has several potential clinical and research applications:

  • Cancer Therapy: Due to its role in angiogenesis, angiogenin is a target for anti-cancer therapies aimed at inhibiting tumor growth by blocking blood vessel formation .
  • Neurodegenerative Diseases: Angiogenin’s neuroprotective properties make it a potential therapeutic agent for neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease .
  • Wound Healing: Recombinant angiogenin can be used to promote wound healing and tissue regeneration in various medical conditions .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.